Treat-and-extend dosing of intravitreal anti-VEGF agents in neovascular age-related macular degeneration: a meta-analysis
Prem Nichani, Marko M. Popovic, Arjan S. Dhoot, Ananya Pathak, Rajeev H. Muni, Peter J. Kertes
Topics & Concepts
MedicineMacular degenerationPro re nataDosingConfidence intervalMeta-analysisVisual acuityOphthalmologyAdverse effectClinical endpointRanibizumabAfliberceptBevacizumabRandomized controlled trialSurgeryInternal medicineChemotherapyRetinal Diseases and TreatmentsRetinal Imaging and AnalysisRetinal and Macular Surgery